Biotech · Private company
H. Lundbeck A/S
Track this companyFree. Adds H. Lundbeck A/S to your Dealase workspace and tells you when its record changes.
Clinical trials259 recruiting or active
Pipeline programs26From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline26
- AmlenetugPhase 3 · Multiple System AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- EptinezumabPhase 3 · Chronic Migraine in ChildrenClinicalTrials.gov · fetched Nov 12, 2026
- EptinezumabPhase 3 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- EptinezumabPhase 3 · Episodic MigraineClinicalTrials.gov · fetched Nov 12, 2026
- EptinezumabPhase 3 · Cluster Headache, EpisodicClinicalTrials.gov · fetched Nov 12, 2026
- EptinezumabPhase 3 · Chronic Cluster HeadacheClinicalTrials.gov · fetched Nov 12, 2026
- Lu AF28996Phase 2 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Lu AF82422Phase 2 · Multiple System AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- Lu AG09222Phase 2 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- Lu AG13909Phase 2 · Cushing's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Lu AG13909Phase 2 · Congenital Adrenal HyperplasiaClinicalTrials.gov · fetched Nov 12, 2026
- Acetylsalicylic AcidPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- Amoxicillin/clavulanic acidPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- CarbamazepinePhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- ItraconazolePhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- Lu AF28996Phase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- Lu AF28996Phase 1 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Lu AG06474Phase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- Lu AH69593Phase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- Mefenamic AcidPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- MidazolamPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- UbrogepantPhase 1 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- ErenumabMigraineClinicalTrials.gov · fetched Nov 12, 2026
- FremanezumabMigraineClinicalTrials.gov · fetched Nov 12, 2026
- GalcanezumabMigraineClinicalTrials.gov · fetched Nov 12, 2026
- Onabotulinumtoxin-AMigraineClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A Trial of Lu AH69593 in Healthy ParticipantsPHASE1 · RECRUITING · started Aug 27, 2026ClinicalTrials.gov NCT07775261 · fetched Nov 12, 2026
- A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor FluctuationsPHASE2 · RECRUITING · started Jul 28, 2026ClinicalTrials.gov NCT07514858 · fetched Nov 12, 2026
- A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP MedicationsPHASE4 · COMPLETED · started Dec 18, 2024ClinicalTrials.gov NCT06701526 · fetched Nov 12, 2026
- A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)PHASE3 · ACTIVE_NOT_RECRUITING · started Dec 3, 2024ClinicalTrials.gov NCT06706622 · fetched Nov 12, 2026
- A Trial Investigating Lu AG09222 With Ubrogepant in Participants With MigrainePHASE1 · COMPLETED · started Sep 13, 2024ClinicalTrials.gov NCT06578585 · fetched Nov 12, 2026
- A Trial of Lu AG13909 in Adult Participants With Cushing's DiseasePHASE2 · ACTIVE_NOT_RECRUITING · started Jun 19, 2024ClinicalTrials.gov NCT06471829 · fetched Nov 12, 2026
- A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive TreatmentsPHASE2 · COMPLETED · started Apr 1, 2024ClinicalTrials.gov NCT06323928 · fetched Nov 12, 2026
- A Trial Investigating Lu AF28996 in Healthy Adult ParticipantsPHASE1 · COMPLETED · started Feb 27, 2024ClinicalTrials.gov NCT06277609 · fetched Nov 12, 2026
- A Study Investigating Lu AG06474 in Healthy Young ParticipantsPHASE1 · TERMINATED · started Jun 28, 2023ClinicalTrials.gov NCT05943327 · fetched Nov 12, 2026
- A Study of Eptinezumab in Pediatric Participants With Episodic MigrainePHASE3 · RECRUITING · started Jun 8, 2023ClinicalTrials.gov NCT05897320 · fetched Nov 12, 2026
- A Trial of Lu AG13909 in Participants With Congenital Adrenal HyperplasiaPHASE1_PHASE2 · RECRUITING · started Dec 19, 2022ClinicalTrials.gov NCT05669950 · fetched Nov 12, 2026
- A Study of Eptinezumab in Participants With Migraine and Medication Overuse HeadachePHASE4 · COMPLETED · started Jul 1, 2022ClinicalTrials.gov NCT05452239 · fetched Nov 12, 2026
- Real World Effectiveness of Eptinezumab in Participants With MigrainePHASE4 · TERMINATED · started Mar 4, 2022ClinicalTrials.gov NCT05284019 · fetched Nov 12, 2026
- A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic MigrainePHASE3 · RECRUITING · started Dec 1, 2021ClinicalTrials.gov NCT05164172 · fetched Nov 12, 2026
- A Study of Lu AF82422 in Participants With Multiple System AtrophyPHASE2 · ACTIVE_NOT_RECRUITING · started Nov 16, 2021ClinicalTrials.gov NCT05104476 · fetched Nov 12, 2026
- A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive TreatmentsPHASE2 · COMPLETED · started Nov 11, 2021ClinicalTrials.gov NCT05133323 · fetched Nov 12, 2026
- A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)PHASE3 · COMPLETED · started Sep 17, 2021ClinicalTrials.gov NCT05064397 · fetched Nov 12, 2026
- A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic MigrainePHASE3 · RECRUITING · started Jun 30, 2021ClinicalTrials.gov NCT04965675 · fetched Nov 12, 2026
- Eptinezumab in Participants With Episodic Cluster HeadachePHASE3 · COMPLETED · started Dec 23, 2020ClinicalTrials.gov NCT04688775 · fetched Nov 12, 2026
- Lu AF28996 in Participants With Parkinson's Disease (PD)PHASE1 · COMPLETED · started Feb 26, 2020ClinicalTrials.gov NCT04291859 · fetched Nov 12, 2026
- Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148PHASE3 · COMPLETED · started Jan 23, 2020ClinicalTrials.gov NCT04258839 · fetched Nov 12, 2026
- Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum DisorderPHASE3 · COMPLETED · started Oct 30, 2019ClinicalTrials.gov NCT04174365 · fetched Nov 12, 2026
- Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With SchizophreniaPHASE3 · COMPLETED · started Aug 23, 2017ClinicalTrials.gov NCT03238326 · fetched Nov 12, 2026
- Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With SchizophreniaPHASE3 · COMPLETED · started Jun 30, 2017ClinicalTrials.gov NCT03198078 · fetched Nov 12, 2026
- Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With SchizophreniaPHASE1 · COMPLETED · started Mar 1, 2015ClinicalTrials.gov NCT02411695 · fetched Nov 12, 2026